Immuno-oncology

The Pharmacy Times® Immuno-oncology Resource Center is a comprehensive resource for clinical news and expert insights on treatments that harness the body's immune system to fight cancer.

Latest News

Microscopic view of bone marrow slide feature are suggestive Multiple myeloma, also known as myeloma, is a type of bone marrow cancer.
FDA Approves Linvoseltamab-gcpt for Treatment of Relapsed or Refractory Multiple Myeloma

July 2nd 2025

The treatment becomes the first approved BCMAxCD3 bispecific antibody with the potential to achieve biweekly or monthly dosing in patients with relapsed/refractory multiple myeloma.

digital representation of car t cells targeting lymphoma cells vibrant and scientific lymphoma car t cell therapy for lymphoma
FDA Removes REMS for Currently Approved BCMA-, CD19-Directed CAR T-Cell Immunotherapies

June 30th 2025

ASCO 2025: Novel Bispecific T-Cell Engager Targeting DLL3 Offers Hope for Refractory Neuroendocrine Carcinomas
ASCO 2025: Novel Bispecific T-Cell Engager Targeting DLL3 Offers Hope for Refractory Neuroendocrine Carcinomas

June 25th 2025

Patient-Centered Management of Dermatologic Toxicities in Oncology: Insights From Cynthia Ryan, PharmD, BCPS
Patient-Centered Management of Dermatologic Toxicities in Oncology: Insights From Cynthia Ryan, PharmD, BCPS

May 17th 2025

AACR 2025: ctDNA-Guided Adjuvant PD-1 Blockade Shows Promise for Patients With Resected dMMR Solid Tumors
AACR 2025: ctDNA-Guided Adjuvant PD-1 Blockade Shows Promise for Patients With Resected dMMR Solid Tumors

April 28th 2025

Latest CME Events & Activities
<1
...
34567